Clinical Trial Update: Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD) [NA]

View source ↗

Summary

A completed clinical trial assessed levetiracetam for Premenstrual Dysphoric Disorder; results are not provided in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Dysphoric Disorder

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: Berkshire Health Systems | Conditions: Premenstrual Dysphoric Disorder | NA | Status: COMPLETED